← 治験一覧に戻る
日常診療におけるブデソニド/グリコピロニウム/フォルモテロール(BGF)の単群試験の統合解析
基本情報
- NCT ID
- NCT06712563
- ステータス
- 募集中
- 試験のフェーズ
- -
- 試験タイプ
- 観察
- 目標被験者数
- 2,000
- 治験依頼者名
- AstraZeneca
概要
The CHOROS pooled analysis is a retrospective secondary data use analysis of integrated individual participant data from a series of planned and on-going primary prospective, non-interventional, multi-center studies sponsored by AstraZeneca and conducted in the pulmonary/primary care practitioner setting in multiple countries and may include data from the following countries: United Kingdom, Germany, Italy, Greece, Japan, Canada and Romania.
対象疾患
慢性閉塞性肺疾患
介入
Budesonide/glycopyrrolate/formoterol fumarate(DRUG)
依頼者(Sponsor)
アストラゼネカ株式会社(INDUSTRY)
IQVIA(INDUSTRY)